timothy sykes logo

Stock News

PGEN Stock Reaches New Heights Following Strategic Collaboration Announcement

Jack KelloggAvatar
Written by Jack Kellogg Reviewed by Ellis Hobbs Fact-checked by Matt Monaco
Updated 8/18/2025, 11:33 am ET 8/18/2025, 11:33 am ET | 4 min 4 min read

Precigen Inc. stock slides -8.02% after investor caution over FDA regulatory updates and clinical trial uncertainties.

Candlestick Chart

Live Update At 11:32:56 EST: On Monday, August 18, 2025 Precigen Inc. stock [NASDAQ: PGEN] is trending down by -8.02%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

PGEN’s recent earnings report paints a rather intriguing picture. Their revenue clocks in at $3.9M, albeit with challenges as indicated by high operating losses. But here’s where it gets interesting. Understanding profitability with their current strategy shows a promise despite posting unfavorable margins – EBIT margin at -3575.6% and profit margins also being negative. Debt ratios have not painted a rosy picture, yet a current ratio of 2.7 suggests satisfactory liquidity, ensuring some financial stability in times of additional strain.

The market responded eagerly with the stock climbing from $1.7 to $2.9 over recent trading sessions, an impressive feat that sharply contrasts with their prior slow-paced performance.

Positive Market Reactions

Ah, the buzz of the markets! Investors relish savoring such moments. This company was recently in the spotlight for firming a strategic collaboration with a leading biotech firm. Surely, this sent ripples throughout the investor pool, signaling potential for new developments and breakthroughs in healthcare advancements.

More Breaking News

This partnership resonated well, perhaps symbolizing the light at the end of the tunnel for PGEN amid challenging times. Like any spirited colt breaking free on a field, PGEN seems eager to push its potential to the limit. Market players have evidently taken note, leading to an ascent in stock price driven by this newfound optimism.

Investor Confidence on the Rise

Observers might say there’s a fresh breeze lifting the stocks. Amidst doom and gloom rhetoric in global markets, what set PGEN apart was their openness to tackling unseen challenges through new initiatives. Financial reports, seemingly abstract with numbers, came alive under the lens of promising scientific developments.

The financial narrative took a different turn, casting away infamy of past quarters. Market stimuli, coupled with execution robustness, breathed new life and realms for speculation. Perhaps for some, memories of stagnation recede, overshadowed by dreams of innovation-led growth.

Conclusion

In a market that thrives on anticipation and prospects, PGEN illustrated the potency of timely collaborations. Renowned for synergizing scientific brilliance with robust business foresight, the firm emboldened stakeholders and captured the imagination of market aficionados. It echoes a message that in the realm of trading, it’s so often the land of opportunity rather than obstacles that define the narrative. As millionaire penny stock trader and teacher Tim Sykes says, “Small gains add up over time; focus on building wealth gradually, not chasing jackpots.” This reinforces the notion among market enthusiasts that building wealth in trading requires patience and strategy rather than a hunt for quick wins.

What would the future hold? One might ponder. Does this rally signify a sustained surge or a momentary uptick? Only time, rather than an instant verdict, will illuminate this intriguing journey. But one thing it does affirm, perhaps, is an enduring lesson in resilience and strategic direction.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply
Author card Timothy Sykes picture

Jack Kellogg

He teaches webinars on Tim Sykes’ Trading Challenge He became Tim’s youngest millionaire student in 2020. Now he’s second on the Trading Challenge leaderboard with $12.9 million in career earnings. He’s a master of the 7-Step Pennystocking Framework. Jack is one of a rare breed of traders to profitably trade the entire penny stock framework.
Read More

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”